Hageman; Gregory S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hageman; Gregory S..The latest application filed is for "predicting age-related macular degeneration with single nucleotide polymorphisms within or near the genes for complement compone".

Company Profile

6.17.57

Hageman; Gregory S. - Salt Lake City UT
Hageman; Gregory S. - Coralville IA US
Hageman; Gregory S. - Coraville IA
Hageman; Gregory S. - Chesterfield MO
Hageman; Gregory S. - St. Louis MO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and reagents for treatment of age-related macular degeneration Grant 11,168,120 - Hageman November 9, 2	2021-11-09
Predicting Age-related Macular Degeneration With Single Nucleotide Polymorphisms Within Or Near The Genes For Complement Compone App 20200270692 - Hageman; Gregory S.	2020-08-27
Methods Of Predicting The Development Of Complement-mediated Disease App 20200239958 - Hageman; Gregory S. ; et al.	2020-07-30
Methods Of Diagnosing And Treating Vascular Associated Maculopathy And Symptoms Thereof App 20200237861 - Hageman; Gregory S. ; et al.	2020-07-30
Methods And Reagents For Treatment Of Age-related Macular Degeneration App 20200165307 - Hageman; Gregory S.	2020-05-28
Genes And Polymorphisms Associated With Age Related Macular Degeneration (amd) App 20200165681 - Hageman; Gregory S.	2020-05-28
Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration App 20180371547 - Hageman; Gregory S.	2018-12-27
Diagnostics and Therapeutics for Macular Degeneration-Related Disorders App 20180335436 - Hageman; Gregory S. ; et al.	2018-11-22
Methods Of Diagnosing And Treating Vascular Associated Maculopathy And Symptoms Thereof App 20180296637 - Hageman; Gregory S. ; et al.	2018-10-18
Methods Of Predicting The Development Of Complement-mediated Disease App 20180155788 - HAGEMAN; GREGORY S. ; et al.	2018-06-07
Methods And Reagents For Treatment Of Age-related Macular Degeneration App 20170369543 - Hageman; Gregory S.	2017-12-28
Genes And Polymorphisms Associated With Amd App 20170356045 - Hageman; Gregory S.	2017-12-14
Predicting Amd With Snps Within Or Near C2, Factor B, Plekha1, Htra1, Prelp, Or Loc387715 App 20170240966 - Hageman; Gregory S.	2017-08-24
Biomarkers Associated With Age-related Macular Degeneration App 20160178641 - Hageman; Gregory S.	2016-06-23
Methods and Reagents for Treatment of Age-Related Macular Degeneration App 20160096871 - Hageman; Gregory S.	2016-04-07
Predicting AMD With SNPS Within or Near C2, Factor B, PLEKHA1, HTRA1, PRELP, or LOC387715 App 20160083794 - Hageman; Gregory S.	2016-03-24
Genes And Polymorphisms Associated With Amd App 20160032381 - Hageman; Gregory S.	2016-02-04
Variants in complement regulatory genes predict age-related macular degeneration Grant 9,063,139 - Allikmets , et al. June 23, 2	2015-06-23
Assessing Susceptibility To Vascular Disorders App 20150148432 - Hageman; Gregory S.	2015-05-28
Rca Locus Analysis To Assess Susceptibility To Amd And Mpgnii App 20150139974 - Hageman; Gregory S.	2015-05-21
Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration App 20150050646 - Hageman; Gregory S.	2015-02-19
Methods Of Predicting The Development Of Complement-mediated Disease App 20140357732 - Hageman; Gregory S. ; et al.	2014-12-04
Methods Of Diagnosing And Treating Vascular Associated Maculopathy And Symptoms Thereof App 20140303013 - Hageman; Gregory S. ; et al.	2014-10-09
Methods and Reagents for Treatment of Age-Related Macular Degeneration App 20130296255 - Hageman; Gregory S.	2013-11-07
Therapeutic compositions for age-related macular degeneration comprising a complement factor H with isoleucine at residue 62 and tyrosine at residue 402 Grant 8,497,350 - Hageman July 30, 2	2013-07-30
Rca Locus Analysis To Assess Susceptibility To Amd And Mpgnii App 20120142608 - Hageman; Gregory S.	2012-06-07
Variants in Complement Regulatory Genes Predict Age-Related Macular Degeneration App 20120071356 - Allikmets; Rando L. ; et al.	2012-03-22
Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration App 20120040884 - Hageman; Gregory S.	2012-02-16
Complement factor H for diagnosis of age-related macular degeneration Grant 8,088,579 - Hageman , et al. January 3, 2	2012-01-03
Variants in complement regulatory genes predict age-related macular degeneration Grant 8,012,683 - Allikmets , et al. September 6, 2	2011-09-06
Diagnostics and Therapeutics for Macular Degeneration-Related Disorders App 20110182908 - Hageman; Gregory S. ; et al.	2011-07-28
Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration Grant 7,867,727 - Hageman January 11, 2	2011-01-11
Predicting Amd With Snps Within Or Near C2, Factor B, Plekha1, Htra1, Prelp, Or Loc387715 App 20100330097 - Hageman; Gregory S.	2010-12-30
Assessing Susceptibility To Vascular Disorders App 20100324154 - Hageman; Gregory S.	2010-12-23
Genes And Polymorphisms Associated With Amd App 20100303832 - Hageman; Gregory S.	2010-12-02
Protective Complement Proteins and Age-Related Macular Degeneration App 20100273720 - Hageman; Gregory S. ; et al.	2010-10-28
Diagnosis Of Abdominal Aortic Aneurysm Using Biomarkers App 20100273267 - Hageman; Gregory S.	2010-10-28
Diagnosis Of Age-related Macular Degeneration Using Biomarkers App 20100240138 - Hageman; Gregory S.	2010-09-23
Methods for treatment of age-related macular degeneration Grant 7,745,389 - Hageman June 29, 2	2010-06-29
Binding Of Complement Factor H To C-reactive Protein App 20100143950 - Hageman; Gregory S. ; et al.	2010-06-10
Diagnostics and therapeutics for macular degeneration-related disorders Grant 7,682,804 - Hageman , et al. March 23, 2	2010-03-23
Diagnosis and Treatment of Age-Related Macular Degeneration App 20090258822 - Hageman; Gregory S.	2009-10-15
Therapeutic Compositions for Age-Related Macular Degeneration App 20090247451 - Hageman; Gregory S.	2009-10-01
Methods And Reagents For Treatment And Diagnosis Of Age-related Macular Degeneration App 20090124542 - Hageman; Gregory S. ; et al.	2009-05-14
Biomarkers Associated With Age-Related Macular Degeneration App 20080318264 - Hageman; Gregory S.	2008-12-25
Protective complement proteins and age-related macular degenration App 20080280825 - Hageman; Gregory S. ; et al.	2008-11-13
Diagnostics and therapeutics for macular degeneration App 20080274453 - Hageman; Gregory S.	2008-11-06
Variants in complement regulatory genes predict age-related macular degeneration App 20080261211 - Allikmets; Rando L. ; et al.	2008-10-23
Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration App 20080152659 - Hageman; Gregory S.	2008-06-26
Protective complement proteins and age-related macular degeneration App 20080146501 - Hageman; Gregory S. ; et al.	2008-06-19
Diagnostics and Therapeutics for Macular Degeneration-Related Disorders App 20080131418 - Hageman; Gregory S. ; et al.	2008-06-05
Diagnostics And Therapeutics For Arterial Wall Disruptive Disorders App 20080118928 - Hageman; Gregory S.	2008-05-22
Diagnostics and therapeutics for macular degeneration-related disorders Grant 7,351,524 - Hageman , et al. April 1, 2	2008-04-01
Diagnostics and therapeutics for macular degeneration-related disorders Grant 7,344,846 - Hageman , et al. March 18, 2	2008-03-18
Nucleic acids encoding interphotoreceptor matrix proteins Grant 7,312,050 - Hageman , et al. December 25, 2	2007-12-25
Diagnostics and therapeutics for ocular disorders App 20070274921 - Hageman; Gregory S. ; et al.	2007-11-29
Methods and reagents for treatment and diagnosis of age-related macular degeneration App 20070020647 - Hageman; Gregory S. ; et al.	2007-01-25
Diagnostics and therapeutics for macular degeneration-related disorders App 20060263819 - Hageman; Gregory S. ; et al.	2006-11-23
Diagnostics and the therapeutics for macular degeneration Grant 7,108,982 - Hageman September 19, 2	2006-09-19
Diagnostics and therapeutics for macular degeneration-related disorders Grant 7,011,952 - Hageman , et al. March 14, 2	2006-03-14
Diagnostics and therapeutics for macular degeneration-related disorders App 20050287601 - Hageman, Gregory S. ; et al.	2005-12-29
Diagnostics and therapeutics for arterial wall disruptive disorders App 20050119536 - Hageman, Gregory S.	2005-06-02
Diagnostics and therapeutics for macular degeneration-related disorders App 20030207309 - Hageman, Gregory S. ; et al.	2003-11-06
Diagnostics and therapeutics for arterial wall disruptive disorders App 20030149997 - Hageman, Gregory S.	2003-08-07
Diagnostics and therapeutics for macular degeneration-related disorders App 20030017501 - Hageman, Gregory S. ; et al.	2003-01-23
Therapeutics and diagnostics for ocular abnormalities App 20020160954 - Hageman, Gregory S. ; et al.	2002-10-31
Diagnostics and therapeutics for ocular disorders App 20020102581 - Hageman, Gregory S. ; et al.	2002-08-01
Diagnostics and therapeutics for macular degeneration-related disorders App 20020015957 - Hageman, Gregory S. ; et al.	2002-02-07
Camouflage materials for reducing visual detection by deer and other dichromatic animals Grant 5,409,760 - Neitz , et al. April 25, 1	1995-04-25
Method for the disinsertion of vitreous body by an enzyme which disrupts or degrades chondroitin sulfate proteoglycan Grant 5,292,509 - Hageman March 8, 1	1994-03-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.